Jane Henderson, CFO of Apogee Therapeutics Inc, sold 6,000 shares at $48.26 each on August 23, 2024. The company focuses on developing therapies for diseases with unmet medical needs. Henderson now holds 200,871 shares.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing